{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:25:28Z","timestamp":1787761528118,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T00:00:00Z","timestamp":1599868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s11126-020-09839-x","type":"journal-article","created":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T11:02:34Z","timestamp":1599908554000},"page":"721-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Clozapine for Treatment-Refractory Aggressive Behavior"],"prefix":"10.1007","volume":"92","author":[{"given":"Teodorescu","family":"Andreea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifteni","family":"Petru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Aliana","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petric","family":"Paula-Simina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima","family":"Lorena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,12]]},"reference":[{"issue":"8","key":"9839_CR1","doi-asserted-by":"publisher","first-page":"e1000120","DOI":"10.1371\/journal.pmed.100012013","volume":"6","author":"S Fazel","year":"2009","unstructured":"Fazel S, Gulati G, Linsell L, Geddes JR, Grann M. Schizophrenia and violence: systematic review and meta-analysis. PLoS Med. 2009;6(8):e1000120. https:\/\/doi.org\/10.1371\/journal.pmed.100012013.","journal-title":"PLoS Med."},{"issue":"9","key":"9839_CR2","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1001\/archgenpsychiatry.2010.97","volume":"67","author":"S Fazel","year":"2010","unstructured":"Fazel S, Lichtenstein P, Grann M, Goodwin GM, L\u00e5ngstr\u00f6m N. Bipolar disorder and violent crime: new evidence from population-based longitudinal studies and systematic review. Arch GenPsychiatry. 2010;67(9):931\u20138.","journal-title":"Arch GenPsychiatry"},{"issue":"1","key":"9839_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ienj.2007.12.001","volume":"16","author":"T Ferns","year":"2008","unstructured":"Ferns T, Cork A. Managing alcohol related aggression in the emergency department (part I). Int Emerg Nurs. 2008;16(1):43\u20137. https:\/\/doi.org\/10.1016\/j.ienj.2007.12.001.","journal-title":"Int Emerg Nurs"},{"key":"9839_CR4","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1001\/jama.1990.03450190043026","volume":"264","author":"DA Regier","year":"1990","unstructured":"Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the epidemiologic catchment area (ECA) study. JAMA. 1990;264:2511\u20138.","journal-title":"JAMA."},{"key":"9839_CR5","first-page":"181","volume-title":"Comprehensive Care of Schizophrenia: a textbook of clinical management","author":"H Meltzer","year":"2001","unstructured":"Meltzer H, Kostakoglu A. Treatment resistant schizophrenia. In: Liberman J, Murray R, editors. Comprehensive Care of Schizophrenia: a textbook of clinical management. London: Martin Dunitz; 2001. p. 181\u2013203."},{"key":"9839_CR6","first-page":"218","volume-title":"Clinical Global Impression: ECDEU Assessment Manual for Psychopharmacology","author":"W Guy","year":"1976","unstructured":"Guy W. Clinical Global Impression: ECDEU Assessment Manual for Psychopharmacology. Rev. ed. Rockville: National Institutes of Mental Health; 1976. p. 218\u201322.","edition":"Rev."},{"issue":"2","key":"9839_CR7","doi-asserted-by":"publisher","first-page":"e222","DOI":"10.1097\/MJT.0000000000000533","volume":"24","author":"P Ifteni","year":"2017","unstructured":"Ifteni P, Szalontay AS, Teodorescu A. Reducing restraint with clozapine in involuntarily admitted patients with schizophrenia. Am J Ther. 2017;24(2):e222\u20136.","journal-title":"Am J Ther."},{"issue":"6","key":"9839_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1176\/ajp.153.6.759","volume":"153","author":"JR Calabrese","year":"1996","unstructured":"Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, Meltzer HY. Clozapine for treatment-refractory mania. Am J Psychiatry. 1996;153(6):759\u201364. https:\/\/doi.org\/10.1176\/ajp.153.6.759.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"9839_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00004850-199703000-00006","volume":"12","author":"B Barbini","year":"1997","unstructured":"Barbini B, Scherillo P, Benedetti F, Crespi G, Colombo C, Smeraldi E. Response to clozapine in acute mania is more rapid than that of chlorpromazine. Int Clin Psychopharmacol. 1997;12(2):109\u201312. https:\/\/doi.org\/10.1097\/00004850-199703000-00006.","journal-title":"Int Clin Psychopharmacol"},{"key":"9839_CR10","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1017\/S1092852900014681","volume":"11","author":"RJ Baldessarini","year":"2006","unstructured":"Baldessarini RJ, Pompili M, Tondo L. Suicide in bipolar disorder: Risks and management. CNS Spectr. 2006;11:465\u201371.","journal-title":"CNS Spectr"},{"key":"9839_CR11","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2147\/NDT.S122367","volume":"13","author":"P Ifteni","year":"2017","unstructured":"Ifteni P, Teodorescu A, Moga MA, Pascu AM, Miclaus RS. Switching bipolar disorder patients treated with clozapine to another antipsychotic medication: a mirror image study. Neuropsychiatr Dis Treat. 2017;13:201\u20134.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"9839_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jad.2014.04.020","volume":"166","author":"P Ifteni","year":"2014","unstructured":"Ifteni P, Correll CU, Nielsen J, Burtea V, Kane JM, Manu P. Rapid clozapine titration in treatment-refractory bipolar disorder. J Affect Disord. 2014;166:168\u201372.","journal-title":"J Affect Disord"},{"issue":"4","key":"9839_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/2045125315584871","volume":"5","author":"C Aksoy Poyraz","year":"2015","unstructured":"Aksoy Poyraz C, Turan \u015e, Demirel \u00d6F, Usta Sa\u011flam NG, Y\u0131ld\u0131z N, Duran A. Effectiveness of ultra-rapid dose titration of clozapine for treatment-resistant bipolar mania: case series. Ther Adv Psychopharmacol. 2015;5(4):237\u201342.","journal-title":"Ther Adv Psychopharmacol"},{"issue":"8","key":"9839_CR14","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/bdi.12018","volume":"14","author":"J Nielsen","year":"2012","unstructured":"Nielsen J, Kane JM, Correll CU. Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study. Bipolar Disord. 2012 Dec;14(8):863\u20139.","journal-title":"Bipolar Disord"},{"issue":"Suppl 3","key":"9839_CR15","first-page":"574","volume":"31","author":"A Wilkowska","year":"2019","unstructured":"Wilkowska A, Wiglusz MS, Cuba\u0142a WJ. Clozapine: promising treatment for suicidality in bipolar disorder. Psychiatr Danub. 2019;31(Suppl 3):574\u20138.","journal-title":"Psychiatr Danub"},{"key":"9839_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/bdi.12271","volume":"17","author":"A Schaffer","year":"2015","unstructured":"Schaffer A, Isomets\u00e4 ET, Tondo L, Moreno D, Turecki G, Reis C, et al. International society for bipolar disorders task force on suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord. 2015;17:1\u201316. https:\/\/doi.org\/10.1111\/bdi.12271.","journal-title":"Bipolar Disord"},{"key":"9839_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/bdi.12272","volume":"17","author":"X-B Li","year":"2015","unstructured":"Li X-B, Tang Y-L, Wang C-Y, de Leon J. Clozapine for treatment resistant bipolar disorder: a systematic review. Bipolar Disord. 2015;17:235\u201347. https:\/\/doi.org\/10.1111\/bdi.12272.","journal-title":"Bipolar Disord"},{"issue":"10","key":"9839_CR18","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.3390\/ijms17101700","volume":"17","author":"M Pompili","year":"2016","unstructured":"Pompili M, Baldessarini RJ, Forte A, Erbuto D, Serafini G, Fiorillo A, Amore M, Girardi P. Do atypical antipsychotics have antisuicidal effects? A hypothesis-generating overview. Int J Mol Sci. 2016;17(10):1700. https:\/\/doi.org\/10.3390\/ijms17101700.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"9839_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1023\/A:1005626100084","volume":"31","author":"R Hammock","year":"2001","unstructured":"Hammock R, Levine WR, Schroeder SR. Brief report: effects of clozapine on self-injurious behavior of two risperidone nonresponders with mental retardation. J Autism Dev Disord. 2001;31(1):109\u201313.","journal-title":"J Autism Dev Disord."},{"issue":"10","key":"9839_CR20","first-page":"440","volume":"55","author":"SA Cohen","year":"1994","unstructured":"Cohen SA, Underwood MT. The use of clozapine in a mentally retarded and aggressive population. J Clin Psychiatry. 1994;55(10):440\u20134.","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"9839_CR21","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1517\/14740338.7.5.525","volume":"7","author":"P Gareri","year":"2008","unstructured":"Gareri P, De Fazio P, Russo E, Marigliano N, De Fazio S, De Sarro G. The safety of clozapine in the elderly. Expert Opin Drug Saf. 2008;7(5):525\u201338. https:\/\/doi.org\/10.1517\/14740338.7.5.525.","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"9839_CR22","doi-asserted-by":"publisher","first-page":"e320","DOI":"10.1097\/MJT.0000000000000735","volume":"25","author":"A Teodorescu","year":"2018","unstructured":"Teodorescu A, Dima L, Ifteni P, Rogozea LM. Clozapine for treatment-refractory behavioral disturbance in dementia. Am J Ther. 2018;25(3):e320\u20135.","journal-title":"Am J Ther."},{"issue":"suppl 14","key":"9839_CR23","first-page":"49","volume":"61","author":"DG Daniel","year":"2000","unstructured":"Daniel DG. Antipsychotic treatment of psychosis and agitation in the elderly. J Clin Psychiatry. 2000;61(suppl 14):49\u201352.","journal-title":"J Clin Psychiatry."},{"issue":"4","key":"9839_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1177\/2045125314532488","volume":"4","author":"SE Argent","year":"2014","unstructured":"Argent SE, Hill SA. The novel use of clozapine in an adolescent with borderline personality disorder. Ther Adv Psychopharmacol. 2014;4(4):149\u201355.","journal-title":"Ther Adv Psychopharmacol."},{"issue":"5","key":"9839_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1177\/2045125313484323","volume":"3","author":"T Zarzar","year":"2013","unstructured":"Zarzar T, McEvoy J. Clozapine for self-injurious behavior in individuals with borderline personality disorder. Ther Adv Psychopharmacol. 2013;3(5):272\u20134.","journal-title":"Ther Adv Psychopharmacol."},{"issue":"1","key":"9839_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1017\/S0790966700010156","volume":"24","author":"E Rutledge","year":"2007","unstructured":"Rutledge E, O'Regan M, Mohan D. Borderline personality disorder and clozapine. Ir J Psychol Med. 2007;24(1):40\u20131.","journal-title":"Ir J Psychol Med"},{"issue":"7","key":"9839_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.4088\/JCP.v60n0710","volume":"60","author":"KN Chengappa","year":"1999","unstructured":"Chengappa KN, Ebeling T, Kang JS, Levine J, Parepally H. Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder. J Clin Psychiatry. 1999;60(7):477\u201384.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"9839_CR28","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-2007-979555","volume":"29","author":"T Steinert","year":"1996","unstructured":"Steinert T, Schmidt-Michel PO, Kaschka WP. Considerable improvement in a case of obsessive-compulsive disorder in an emotionally unstable personality disorder, borderline type under treatment with clozapine. Pharmacopsychiatry. 1996;29(3):111\u20134.","journal-title":"Pharmacopsychiatry."},{"issue":"2","key":"9839_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.9758\/cpn.2016.14.2.226","volume":"14","author":"B Amamou","year":"2016","unstructured":"Amamou B, Salah WB, Mhalla A, Benzarti N, Elloumi H, Zaafrane F, Gaha L. Use of clozapine for borderline personality disorder: a case report. Clin Psychopharmacol Neurosci. 2016;14(2):226\u20138.","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"5","key":"9839_CR30","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1017\/S1092852914000157","volume":"19","author":"D Brown","year":"2014","unstructured":"Brown D, Larkin F, Sengupta S, Romero-Ureclay JL, Ross CC, Gupta N, Vinestock M, Das M. Clozapine: an effective treatment for seriously violent and psychopathic men with antisocial personality disorder in a UK high-security hospital. CNS Spectr. 2014;19(5):391\u2013402.","journal-title":"CNS Spectr"},{"issue":"6","key":"9839_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/0010-440X(93)90065-C","volume":"34","author":"FR Frankenburg","year":"1993","unstructured":"Frankenburg FR, Zanarini MC. Clozapine treatment of borderline patients: a preliminary study. Compr Psychiatry. 1993;34(6):402\u20135.","journal-title":"Compr Psychiatry"},{"issue":"2","key":"9839_CR32","first-page":"125","volume":"25","author":"C Frogley","year":"2013","unstructured":"Frogley C, Anagnostakis K, Mitchell S, Mason F, Taylor D, Dickens G, Picchioni MM. A case series of clozapine for borderline personality disorder. Ann Clin Psychiatry. 2013;25(2):125\u201334.","journal-title":"Ann Clin Psychiatry"},{"issue":"3","key":"9839_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1176\/appi.ps.53.3.348-a","volume":"53","author":"GF Parker","year":"2002","unstructured":"Parker GF. Clozapine and borderline personality disorder. Psychiatr Serv. 2002;53(3):348\u20139.","journal-title":"Psychiatr Serv"},{"issue":"1","key":"9839_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1521\/pedi.1995.9.1.76","volume":"9","author":"KNR Chengappa","year":"1995","unstructured":"Chengappa KNR, Baker RW, Sirri C. The successful use of clozapine in ameliorating severe self mutilation in a patient with borderline personality disorder. J Personal Disord. 1995;9(1):76\u201382.","journal-title":"J Personal Disord"},{"issue":"1","key":"9839_CR35","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1017\/S0790966700010156","volume":"24","author":"E Rutledge","year":"2007","unstructured":"Rutledge E, O\u2019Regan M, Mohan D. Borderline personality disorder and clozapine. Ir J Psychol Med. 2007;24(1):40\u20131.","journal-title":"Ir J Psychol Med"},{"issue":"3","key":"9839_CR36","doi-asserted-by":"publisher","first-page":"267","DOI":"10.4103\/0019-5545.70989","volume":"52","author":"AK Vohra","year":"2010","unstructured":"Vohra AK. Treatment of severe borderline personality disorder with clozapine. Indian J Psychiatry. 2010;52(3):267\u20139.","journal-title":"Indian J Psychiatry"}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-020-09839-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11126-020-09839-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-020-09839-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T23:51:20Z","timestamp":1631404280000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11126-020-09839-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,12]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["9839"],"URL":"https:\/\/doi.org\/10.1007\/s11126-020-09839-x","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,12]]},"assertion":[{"value":"30 August 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"In the last 3\u00a0years, TA and IP have received honoraria for consulting or lectures from Lundbeck, Janssen and Angelini.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"This research present results of clozapine efficacy in another psychiatric disease except schizophrenia and schizoaffective disorder. This treatment is approved by the hospital\u2019s protocols for psychiatric emergencies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research Involving Human Participants and\/or Animals"}},{"value":"The written informed consent for this research was obtain from all patients at admission.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}